MEEI
Welcome,         Profile    Billing    Logout  
 2 Trials 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Hanlon, Grayson
NCT04417530: Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma

Active, not recruiting
2
22
US
AU-011, Suprachoroidal Microinjector, PDT Laser
Aura Biosciences
Uveal Melanoma, Ocular Melanoma, Choroidal Melanoma
05/24
05/25
Spectra, NCT05393284: Phase 2 Study to Evaluate the Safety and Efficacy of OPL-0401 in Patients With Diabetic Retinopathy

Active, not recruiting
2
114
US
OPL-0401 Dose 1, Placebo
Valo Health, Inc.
Non-proliferative Diabetic Retinopathy, Proliferative Diabetic Retinopathy
08/24
08/24
ContactLens, NCT04225611: Therapeutic Contact Lens Drug Delivery System (TCL-DDS) in Patients With Recurrent Cystoid Macular Edema

Recruiting
1/2
6
US
Dexamethasone, (TCL-DDS)
Massachusetts Eye and Ear Infirmary
Cystoid Macular Edema
12/23
12/24
NCT03941379: A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma

Recruiting
N/A
500
US
Aura Biosciences
Choroidal Melanoma, Indeterminate Lesions of Eye
12/29
12/29

Download Options